Pr. Montalescot reports research Grants to the Institution or Consulting/Lecture Fees from Abbott, Amgen, Actelion, AstraZeneca, Bayer, Boehringer Ingelheim, Boston-Scientific, Bristol-Myers Squibb, Beth Israel Deaconess Medical, Brigham Women’s Hospital, Cardiovascular Research Foundation, Daiichi-Sankyo, Idorsia, Lilly, Europa, Elsevier, Fédération Française de Cardiologie, ICAN, Medtronic, Journal of the American College of Cardiology, Lead-Up, Menarini, MSD, Novo-Nordisk, Pfizer, Sanofi, Servier, The Mount Sinai School, TIMI Study Group, WebMD.

Pr. JP Collet declare institutional research funding or fees from d’AstraZeneca, Bayer, Bristol-Myers Squibb, Daiichi-Sankyo, Eli-Lilly, Fédération Française de Cardiologie, Lead-Up, Medtronic, MSD, Sanofi-Aventis, WebMD.

Pr. G. Cayla declare institutional research funding or fees from d’Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Boston, Biotronik, Bristol-Myers Squibb, Daiichi-Sankyo, Eli-Lilly, Europa, Fédération Française de Cardiologie, Fondation Cœur & Recherche, Medtronic, MSD, Pfizer, Sanofi-Aventis, The Medicines Company.

Pr. J. Silvain declare institutional research funding or fees from Amgen, Algorythm, Astra-Zeneca , Bayer, Gilead Science, Bristol-Myer Squibb et Sanofi-Aventis.

Dr. M. Kerneis declare institutional research funding or fees from Sanofi, Fédération Française de Cardiologie, Société Française de Cardiologie, ESC, AstraZeneca, Daiichi-Sankyo, Lilly, Bayer.

Dr. A. Bellemain-Appaix declare institutional research funding or fees from d’Abbott, AstraZeneca, Biosensor, Biotronik, Daiichi-Sankyo, Eli-Lilly, The Medicines Company et Novartis.

Dr. P. Sabouret declare fees from d’AstraZeneca, Bayer, BMS, Boehringer, Daiichi, Eli-Lilly, MSD, Novartis, Pfizer, Amgen.

Pr. JS Hulot declare institutional research funding or fees from d’AstraZeneca, Bristol-Myers Squibb, Celladon, Chiesi, Daiichi-Sankyo, Fédération Française de Cardiologie, Fondation Coeur et Recherche, Fondation Leducq, Fondation Simone et Cino Del Duca, France Génomique, Novartis, Sanofi.

Pr. Isnard declare institutional research funding or fees from Novartis, BMS, Servier, Daiichi Sankyo, Bayer, Abbott, Vifor et Zoll